Neumora Therapeutics, Inc.
NMRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001885522
In the last 90 days, Neumora Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 113 institutions reported holding it in 13F filings for Q2 2026, worth $129.2M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Neumora Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 60
- +22 vs. Q3 2023
- Shares held
- 43.7M
- +7.39M (+20.3%) vs. Q3 2023
- Total value
- $744.8M
- +$232.8M (+45.5%) vs. Q3 2023
- New holders
- 34
- 9 more added
- Sold out
- 12
- 8 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $129.2M |
| Q1 2026 | 114 | $137.2M |
| Q4 2025 | 102 | $112.7M |
| Q3 2025 | 93 | $92.2M |
| Q2 2025 | 98 | $41.1M |
| Q1 2025 | 116 | $65.2M |
| Q4 2024 | 135 | $851.6M |
| Q3 2024 | 104 | $907.0M |
| Q2 2024 | 93 | $627.4M |
| Q1 2024 | 88 | $725.4M |
| Q4 2023 | 60 | $744.8M |
| Q3 2023 | 38 | $512.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Neumora Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quarry LP | 50 | $853 | 0.00% | +50 | New |
| Advisory Services Network, LLC | 200 | $3.41K | 0.00% | +200 | New |
| UBS Group AG | 256 | $4.37K | 0.00% | +256 | New |
| Metropolitan Life Insurance Co | 921 | $15.7K | 0.00% | +921 | New |
| Legal & General Group Plc | 1,422 | $24.2K | 0.00% | −8,578−85.8% | Reduced |
| Ameritas Investment Partners, Inc. | 1,540 | $26.3K | 0.00% | +1,540 | New |
| Amalgamated Bank | 1,709 | $29.0K | 0.00% | +1,709 | New |
| California State Teachers Retirement System | 2,449 | $41.8K | 0.00% | +2,449 | New |
| Tower Research Capital LLC (TRC) | 2,558 | $43.6K | 0.00% | +2,558 | New |
| STRS Ohio | 3,200 | $54.0K | 0.00% | +3,200 | New |
| Royal Bank of Canada | 4,939 | $84.0K | 0.00% | −15,139−75.4% | Reduced |
| Citigroup Inc | 5,746 | $98.0K | 0.00% | −8,670−60.1% | Reduced |
| Virtus ETF Advisers LLC | 6,328 | $107.9K | 0.07% | +6,328 | New |
| SG Americas Securities, LLC | 6,308 | $108.0K | 0.00% | +6,308 | New |
| New York State Common Retirement Fund | 6,900 | $117.6K | 0.00% | +6,900 | New |
| American International Group, Inc. | 7,394 | $126.1K | 0.00% | +7,394 | New |
| Deutsche Bank AG | 8,007 | $136.5K | 0.00% | +8,007 | New |
| MetLife Investment Management | 8,487 | $144.7K | 0.00% | +8,487 | New |
| Ghisallo Capital Management LLC | 10,000 | $170.5K | 0.02% | 00.0% | Unchanged |
| Legacy Private Trust Co. | 10,000 | $170.5K | 0.01% | +10,000 | New |
| Susquehanna International Group, LLP | 11,327 | $193.1K | 0.00% | −17,507−60.7% | Reduced |
| Renaissance Technologies LLC | 13,600 | $232.0K | 0.00% | +13,600 | New |
| Bank of America Corp | 15,120 | $257.8K | 0.00% | +15,120 | New |
| Rhumbline Advisers | 15,720 | $268.0K | 0.00% | +15,720 | New |
| Barclays PLC | 20,539 | $350.2K | 0.00% | +20,539 | New |
| Nuveen Asset Management, LLC | 20,749 | $353.8K | 0.00% | +20,749 | New |
| Wells Fargo & Company | 27,355 | $466.4K | 0.00% | +27,355 | New |
| Morgan Stanley | 31,079 | $529.9K | 0.00% | +30,679+7,669.8% | Added |
| Bank of New York Mellon Corp | 45,200 | $770.7K | 0.00% | +45,200 | New |
| Gsa Capital Partners LLP | 46,883 | $799.0K | 0.07% | +46,883 | New |
| Norges Bank | 50,000 | $852.5K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 61,117 | $1.04M | 0.00% | +61,117 | New |
| Jane Street Group, LLC | 89,339 | $1.52M | 0.00% | +89,339 | New |
| Cormorant Asset Management, LP | 92,293 | $1.57M | 0.08% | 00.0% | Unchanged |
| Alps Advisors Inc | 105,990 | $1.81M | 0.01% | +105,990 | New |
| Scoggin Management LP | 125,000 | $2.13M | 2.30% | −25,000−16.7% | Reduced |
| Northern Trust Corp | 126,444 | $2.16M | 0.00% | +126,444 | New |
| Charles Schwab Investment Management Inc | 129,912 | $2.21M | 0.00% | +129,912 | New |
| GMT Capital Corp | 140,666 | $2.40M | 0.09% | +140,666 | New |
| State Street Corp | 141,478 | $2.41M | 0.00% | +141,478 | New |
| Ensign Peak Advisors, Inc | 150,000 | $2.56M | 0.01% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 263,000 | $4.48M | 0.04% | +263,000 | New |
| Vanguard Group Inc | 380,954 | $6.50M | 0.00% | +330,954+661.9% | Added |
| Logos Global Management LP | 382,345 | $6.52M | 0.72% | +382,345 | New |
| Alphabet Inc. | 404,732 | $6.90M | 0.32% | +205,124+102.8% | Added |
| Geode Capital Management, LLC | 436,877 | $7.45M | 0.00% | +314,691+257.6% | Added |
| Goldman Sachs Group Inc | 592,422 | $10.1M | 0.00% | +518,822+704.9% | Added |
| BlackRock Inc. | 1,044,004 | $17.8M | 0.00% | +1,019,004+4,076.0% | Added |
| OrbiMed Advisors LLC | 1,500,000 | $25.6M | 0.51% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,699,313 | $29.0M | 0.58% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,843,291 | $30.3M | 0.03% | −325,227−15.0% | Reduced |
| Johnson & Johnson | 1,849,445 | $31.5M | 0.72% | +937,317+102.8% | Added |
| Avidity Partners Management LP | 1,990,632 | $33.9M | 1.30% | +190,632+10.6% | Added |
| EcoR1 Capital, LLC | 2,071,450 | $35.3M | 0.92% | 00.0% | Unchanged |
| Artal Group S.A. | 2,552,702 | $43.5M | 1.48% | −250,000−8.9% | Reduced |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 3,309,123 | $56.4M | 0.70% | −10.0% | Reduced |
| ICONIQ Capital, LLC | 3,398,628 | $57.9M | 1.10% | +3,398,628 | New |
| MIC Capital Management UK LLP | 4,460,700 | $76.1M | 14.76% | 00.0% | Unchanged |
| FMR LLC | 6,373,129 | $108.7M | 0.01% | +748,776+13.3% | Added |
| Softbank Group Corp | 7,646,916 | $130.4M | 0.70% | 00.0% | Unchanged |
| Soros Capital Management LLC | 0 | $0 | 0.00% | −588,235−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −274,748−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −256,412−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −58,500−100.0% | Sold out |
| Greenland Capital Management LP | 0 | $0 | 0.00% | −47,613−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −43,713−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −26,770−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −21,557−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −21,400−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |